Ami Fadia

Ami Fadia, AMRN, Analyst Color, Analyst Ratings, Benzinga, Biotech, Coronavirus, COVID-19, Hikma Biologics, Legal, News, Price Target, RDY, Reiteration, SVB Leerink, Trading Ideas, US0231112063, US2561352038, Vascepa

Generic Threat To Amarin’s Vascepa Overrides Positive Sentiment On Coronavirus Announcement

Amarin Corporation plc (NASDAQ: AMRN) shares, which were higher in after-hours trading Thursday following the company’s announcement regarding a third-party pilot trial of its Vascepa in COVID-19, were giving back the gains Friday. 

Latest Ratings f…